Fund Houses Recommendations: MAHINDRA, MARICO, VEDANTA, NYKAA, INFOSYS, ZOMATO, IIFL, DRREDDY

અમદાવાદ, 18 જૂનઃ અગ્રણી બ્રોકરેજ હાઉસ તથા ફન્ડ હાઉસ દ્વારા પસંદગીના શેર્સમાં ખરીદી/ વેચાણ/ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

GS on M&M: Maintain Buy on Company, raise target price at Rs 3090 (Positive)

Jefferies on M&M: Maintain Buy on Company, raise price at Rs 3510 (Positive)

Nomura on M&M: Maintain Buy on Company, raise price at Rs 3374 (Positive)

JP Morgan on Marico: Maintain Overweight on Company, raise price at Rs 660 (Positive)

Investec on Vedanta: Upgrade to Hold on Company, raise target price at Rs 345 (Positive)

Nuvama on Vedanta: Maintain Buy on Company, raise target price at Rs 644 (Positive)

CLSA on Vedanta: Maintain Buy on Company, raise target price at Rs 520 (Positive)

MOSL on Vedanta: Maintain Neutral on Company, raise target price at Rs 500 (Positive)

MS on Nykaa: Maintain Overweight on Company, target price at Rs 198 (Positive)

Nomura on Nykaa: Maintain Neutral on Company, target price at Rs 203 (Positive)

Citi on Infosys: Maintain Buy on Company, target price at Rs 1785 (Positive)

JP Morgan on Zomato: Maintain Overweight on Company, target price at Rs 208 (Positive)

Jefferies on Financials: Max Life sees steady growth and limited impact of new norms, ICICI Lombard is confident on growth and better margins, CMS Info sees healthy growth & diversification (Positive)

Macquarie on Nykaa: Maintain Underperform on Company, target price at Rs 135 Neutral)

BofA on Nykaa: Maintain Neutral on Company, target price at Rs 186 (Neutral)

Jefferies on Infosys: Maintain Buy on Company, target price at Rs 1630 (Neutral)

CLSA on Infosys: Maintain Buy on Company, target price at Rs 1553 (Neutral)

Jefferies on M&M Fin: Maintain Hold on Company, target price at Rs 294 (Neutral)

Jefferies on IIFL Fin: Maintain Hold on Company, target price at Rs 465 (Neutral)

Jefferies on Dr Reddy: Maintain Underperform on Company, target price at Rs 5010 (Neutral)

Citi on Dr Reddy: Maintain Sell on Company, target price at Rs 5200 (Neutral)

Citi on RBL Bank: Maintain Sell on Company, target price at Rs 257 (Neutral)

Citi on Auro Pharma: Maintain Sell on Company, target price at Rs 1040 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)